Where in the World are Chinese Women Filmmakers? Transnational China and World Cinema in the Twenty-First Century
Studies in World Cinema · 24.11.2021 · 1 (2) · 121-144
DOI: 10.1163/26659891-01020002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in World Cinema, erschienen am 24.11.2021. Verfasst von Gina Marchetti. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transnational Chinese women filmmakers reflect the enormous changes happening in the global film industry as well as political, economic, technological, social, and cultural transformations taking place in the region since the beginning of the millennium. An analysis of Hong Kong writer-director Aubrey Lam’s Anna & Anna (2007) uncovers how this film explores the divided psyche of a woman torn between “two systems” that model femininity for women in Singapore and Shanghai in the 21st century. Lam’s narrative touches on issues central to the work of many women working across the Chinese-speaking world including migration, labor relations, postcolonial and postsocialist identities, commodification of female bodies in consumer culture, cross-border sexualities, female desire and domesticity.
Zitieren
APA
Marchetti, G. (2021). Where in the World are Chinese Women Filmmakers? Transnational China and World Cinema in the Twenty-First Century. Studies in World Cinema, 1(2), 121-144. https://doi.org/10.1163/26659891-01020002
Vancouver
Marchetti G. Where in the World are Chinese Women Filmmakers? Transnational China and World Cinema in the Twenty-First Century. Studies in World Cinema. 2021;1(2):121-144. doi:10.1163/26659891-01020002
BibTeX
@article{Marchetti2021,
author = {Marchetti, Gina},
title = {Where in the World are Chinese Women Filmmakers? Transnational China and World Cinema in the Twenty-First Century},
journal = {Studies in World Cinema},
year = {2021},
volume = {1},
number = {2},
pages = {121--144},
doi = {10.1163/26659891-01020002}
}
EUVIMED